Invention Grant
- Patent Title: Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene
-
Application No.: US14493058Application Date: 2014-09-22
-
Publication No.: US10039725B2Publication Date: 2018-08-07
- Inventor: Jeremy Bartos , Ryan Dellinger
- Applicant: ChromaDex Inc. , The Regents of the University of California
- Applicant Address: US CA Irvine US CA Oakland
- Assignee: ChromaDex Inc.,The Regents of the Unviersity of California
- Current Assignee: ChromaDex Inc.,The Regents of the Unviersity of California
- Current Assignee Address: US CA Irvine US CA Oakland
- Agency: Amin Talati Upadhye LLP
- Agent George M. Carrera, Jr.; Jonathan J. Krit
- Main IPC: A61K31/09
- IPC: A61K31/09
Abstract:
A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.
Public/Granted literature
Information query
